Hopefully this not impact on IMU's planned meeting next month
The drug industry's biggest shutdown fear has come true: The FDA is almost broke, and that's delaying new approvals. Aimmune Therapeutics, which filed its peanut allergy treatment the day before the shutdown, got word last night that the FDA won't consider its application until funding is restored.
https://www.statnews.com/2019/01/14...mp;utm_term=0_8cab1d7961-0df878b5d4-150193645
Hopefully this not impact on IMU's planned meeting next month...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.002(5.41%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 4.0¢ | 3.5¢ | $1.163M | 31.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2275218 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 196677 | 3 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
